The mprotein monoclonal immunoglobulin protein produced by the malignant plasma cells is igg in about 55% of myeloma patients and iga in about 20%. Pathophysiology of multiple myeloma bone disease request pdf. Request pdf pathophysiology of multiple myeloma bone disease multiple myeloma is a plasma cell malignancy characterized by the frequent development of osteolytic bone lesions. Multiple myeloma and related disorders pathophysiology of blood. The bone marrow produces red blood cells, which carry oxygen throughout the body. Get an overview of multiple myeloma and the latest key statistics in the us. The multiple myelomainduced bone destruction is a result of the increased activity of osteoclasts that occurs adjacent to multiple myeloma cells. Multiple myeloma can also affect your bones, leading to bone pain, thinning bones and broken bones. By far, the most important of these tumors is multiple myeloma, which is diagnosed. Myeloma cells inhibit your bodys ability to fight infections. Myeloma most often grows in the marrow within the bones of the spine, skull, pelvis, rib cage, shoulders, and hips. What is the pathophysiology of solitary plasmacytoma. Usually, the bones of the hands, feet, and lower parts of the arms and legs are not affected, preserving the function of these critical areas.
Early mortality after diagnosis of multiple myeloma. Multiple myeloma hematology and oncology merck manuals. Multiple myeloma mm is a bcell malignancy characterized by the clonal proliferation of. Epidemiology and pathophysiology multiple myeloma accounts for 1. Multiple myeloma mm is a plasma cell malignancy in which monoclonal plasma cells proliferate in bone marrow, resulting in an overabundance of monoclonal paraprotein m protein, destruction of bone, and displacement of other hematopoietic cell lines. Multiple myeloma is a cancer that develops in the bone marrow, the spongy tissue found in the center of most bones. Multiple myeloma is a plasma cell malignancy characterized by the frequent development of osteolytic bone lesions.
Pdf myeloma bone disease mbd is a devastating complication of multiple myeloma mm. Pdf advances in the imaging and treatment of multiple myeloma have occurred over the past. Pathophysiology and diagnosis of multiple myeloma jatin shah, md, explains that there is no clear reason for why patients develop multiple myeloma, and so theres no clear risk factor. What is the pathophysiology of multiple myeloma mm. Serum free light chain assay in all patients with newly diagnosed plasma cell dyscrasias. The myeloma xi study showed a significant improvement in progressionfree survival from 28. Cellular interactions in the bone marrow microenvironment in myeloma bone disease. Find out how multiple myeloma is tested for, diagnosed, and staged.
More than 80% of mm patients suffer from destructive bony lesions, leading to pain, fractures, mobility issues. Multiple myeloma is a malignancy of terminally differentiated plasma cells, and patients typically present with bone marrow infiltration of clonal plasma cells. Multiple myeloma represents 2% of all new cancer diagnoses in the united. Learn about the risk factors for multiple myeloma and what you might be able to do to help lower your risk. Learn more about the symptoms, causes, diagnosis, risk factors, and treatment of multiple myeloma. Myeloma bone disease mbd is a devastating complication of multiple myeloma mm. Multiple myeloma is a neoplastic plasmacell disorder that is characterized by clonal proliferation of malignant plasma cells in the bone marrow microenvironment, monoclonal protein in the blood or. The bone marrow microenvironment in myeloma includes osteoblasts obl, osteoclasts ocl, stromal cells, endothelial cells, and osteocytes. A solitary bone plasmacytoma sbp arises from the plasma cells located in the bone marrow.
432 593 502 72 751 257 560 1460 357 1168 14 749 1380 733 1313 604 677 775 477 425 398 803 1078 1014 34 362 489 1360 1303 137 670 593 878 418 350 439